
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Clostridium butyricum MIYAIRI 588 is a spore-forming probiotic strain that produces butyric acid in the colon to support digestive health and immune function. This beneficial bacterium strengthens the intestinal barrier and modulates inflammatory responses through short-chain fatty acid production.

Reported Benefits (Provisional)
Origin & History

Clostridium butyricum is a spore-forming bacterium naturally found in the human gut and soil. It is cultured for use in supplements to support digestive health and balance gut flora.
Research Narrative (Provisional)
Research, including RCTs, indicates that Clostridium butyricum can help improve gut health and treat conditions like irritable bowel syndrome and ulcerative colitis.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Reported Mechanism (Provisional)
Clostridium butyricum MIYAIRI 588 ferments dietary fiber to produce butyric acid, which serves as the primary energy source for colonocytes and strengthens tight junction proteins in the intestinal barrier. Butyric acid activates GPR41 and GPR43 receptors on immune cells, promoting regulatory T-cell differentiation and reducing pro-inflammatory cytokine production. The strain also produces vitamin B12 and competes with pathogenic bacteria for colonization sites.
Clinical Narrative (Provisional)
Human studies with Clostridium butyricum MIYAIRI 588 include randomized controlled trials in patients with irritable bowel syndrome and antibiotic-associated diarrhea. A 12-week study of 60 IBS patients showed 40% improvement in abdominal pain scores compared to placebo. Research in elderly patients demonstrated reduced duration of antibiotic-associated diarrhea from 5.2 to 2.8 days. However, most clinical evidence comes from small-scale studies, and larger trials are needed to confirm therapeutic benefits.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







